The report Huntington's Disease Market focuses on major leading Market players, Key market segments and sub-segments to provide comprehensive and insightful data
Presented in an easy to understand table format, this report provides the current prevalent population for Huntington’s disease across 8 Major Markets (USA, France, Germany, Italy, Spain, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report provides a 10-year forecast projection based on population trends in each of the major markets.
The report also contains a disease overview including risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Providing a value-added level of insight from the analysis team , several of the main symptoms and co-morbidities of Huntington’s patients have been quantified and presented alongside the overall prevalence figures.
Main symptoms and co-morbidities for Huntington’s disease include:
• Total functional capacity by stage
• Nervous system dysfunction
• Psychiatric disorders
• Cognitive disorders
• Major depressive disorder
• Personality changes
• Anxiety disorders
• Moderate / Severe Sleep disturbance
The report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.
All of the sources used to generate the data and analysis have been identified in the report.
For more information:Make an Inquiry about this report HERE!